会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明公开
    • 1,4-Dihydropyridine derivatives
    • -1,4-二氢吡啶衍生物在。
    • EP0106276A2
    • 1984-04-25
    • EP83109969.2
    • 1983-10-05
    • KYOWA HAKKO KOGYO CO., LTD.
    • Watanabe, MinoruMuto, KenjiSugaya, ToruKuroda, TokuyukiHashimoto, TamotsuYamada, KojiNakamizo, Nobuhiro
    • C07D211/90C07D405/14C07D409/14A61K31/455
    • C07D405/14C07D211/46C07D211/72C07D211/74C07D211/90C07D409/14
    • A 1,4-dihydropyridine derivative having hypotensive activity is represented by the formula (I):
      in which one of R, and R 2 represents an alkyl group or a group of the formula (II):
      in which R 5 represents an alkoxy group or a substituted or unsubstituted heterocyclic group and n represents 0 or an integer of 1 - 3, and the other of R, and R 2 represents a group of the formula (III):
      in which R 6 represents a substituted or unsubstituted aralkyl group and R 7 , R 8 , R 9 , R 10 , R 11 and R 12 are the same or different groups and each represertts hydrogen or an alkyl group, and two alkyl groups may be attached to one carbon atom on the piperidine ring. When R, is an alkyl group and R a is an unsubstituted aralkyl group, at least one of R 7 , R s , R s , R 10 , R 11 and R 12 represents an alkyl group. Also disclosed are pharmaceutically acceptable acid addition salts of compound (I).
    • 具有降血压活性的1,4-二氢吡啶衍生物由式(I)表示:其中R 1和R 2中的一个表示烷基或式(II)的基团: - (CH 2)n -R5(II)...其中R5表示烷氧基或取代或未取代的杂环基,n表示0或1-3的整数,R1和R2中的另一个表示式(III)的基团: 其中R 6表示取代或未取代的芳烷基,且R 7,R 8,R 9,R 10,R 11和R 12为相同或不同的基团,各自表示氢或烷基,两个烷基可以连接到一个 碳原子在哌啶环上。 当R 1为烷基且R 6为未取代的芳烷基时,R 7,R 8,R 9,R 10,R 11和R 12中的至少一个为烷基。 还公开了化合物(I)的药学上可接受的酸加成盐。